Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.
Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded UC Davis Medical Center in Sacramento, CA, increasing total locations to 90; the Last Update Posted field shows an estimated date.SummaryDifference1%
- Check40 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference4%
- Check47 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check62 days agoChange DetectedUpdated from v3.0.1 to v3.0.2, signaling a new release with potential minor fixes. The removal of the 'Back to Top' link is a minor UI change and core content remains unchanged.SummaryDifference0.2%
- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location details, while removing previous location references and a specific resource related to chronic graft versus host disease.SummaryDifference2%
Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.